About this document

PDE-5 Inhibitors for Diabetes-Related ED by Shaney_fl is a document available to read on EtoBox.

This document summarizes clinical trials evaluating the use of phosphodiesterase type 5 (PDE-5) inhibitors to treat erectile dysfunction (ED) in patients with diabetes. It discusses four randomized, placebo-controlled trials of sildenafil (Viagra), tadalafil, and vardenafil that found all active drugs were significantly more effective than placebo at improving erections in men with diabetes-related ED. The greatest response rate was seen with vardenafil 20mg, with 72% of men reporting improved erections ver

Author

Shaney_fl

Language

EN